Norman, OK, United States of America

Xiaozheng Dou


Average Co-Inventor Count = 3.8

ph-index = 1


Company Filing History:


Years Active: 2022-2025

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations of Xiaozheng Dou in Ocular Disease Treatment

Introduction

Xiaozheng Dou is an accomplished inventor based in Norman, OK (US). He has made significant contributions to the field of medicine, particularly in the treatment of ocular diseases. With a total of 3 patents, his work focuses on enhancing therapeutic approaches for conditions involving inflammation and angiogenesis.

Latest Patents

Xiaozheng Dou's latest patents include innovative compounds that act as agonists of peroxisome proliferator-activated receptor alpha (PPARα). These patents detail benzyl derivative compounds that possess PPARα agonistic activity. The methods of use outlined in these patents aim to treat various ocular diseases and conditions, such as retinal inflammation, retinal neovascularization, and diabetic retinopathy. His research emphasizes the potential of these compounds in enhancing PPARα activity to address diseases characterized by inflammation and angiogenesis.

Career Highlights

Xiaozheng Dou is affiliated with the University of Oklahoma, where he conducts his research and development. His work has garnered attention for its innovative approach to treating complex ocular conditions. His dedication to advancing medical science is evident through his patent portfolio and ongoing research efforts.

Collaborations

Xiaozheng Dou collaborates with notable colleagues, including Adam Duerfeldt and Ziwei Hu. These partnerships enhance the research environment and contribute to the development of groundbreaking solutions in the field of ocular health.

Conclusion

Xiaozheng Dou's contributions to the field of ocular disease treatment through his innovative patents highlight his role as a leading inventor. His work continues to pave the way for new therapeutic strategies that can significantly impact patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…